A new stem cell treatment in Australia designed to treat the root cause of Parkinson's disease has received approval for human testing. Cyto Therapeutics will conduct the clinical trial at The Royal Melbourne Hospital.
A new stem cell treatment in Australia designed to treat the root cause of Parkinson's disease has received approval for human testing. Cyto Therapeutics will conduct the clinical trial at The Royal Melbourne Hospital.